Aptus Capital Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.3M Buy
136,445
+13,171
+11% +$2.44M 0.21% 92
2025
Q1
$25.8M Buy
123,274
+9,959
+9% +$2.09M 0.27% 76
2024
Q4
$20.1M Buy
113,315
+29,972
+36% +$5.33M 0.21% 96
2024
Q3
$16.5M Buy
83,343
+14,457
+21% +$2.85M 0.25% 96
2024
Q2
$11.8M Buy
68,886
+13,887
+25% +$2.38M 0.21% 97
2024
Q1
$10M Buy
54,999
+4,673
+9% +$851K 0.19% 97
2023
Q4
$7.8M Sell
50,326
-4,844
-9% -$751K 0.21% 98
2023
Q3
$8.22M Buy
55,170
+874
+2% +$130K 0.22% 88
2023
Q2
$7.32M Sell
54,296
-12,873
-19% -$1.73M 0.18% 101
2023
Q1
$10.7M Buy
67,169
+3,705
+6% +$590K 0.29% 71
2022
Q4
$10.3M Buy
63,464
+7,903
+14% +$1.28M 0.31% 64
2022
Q3
$7.46M Sell
55,561
-17,458
-24% -$2.34M 0.18% 72
2022
Q2
$11.2M Buy
73,019
+26,921
+58% +$4.12M 0.29% 43
2022
Q1
$7.47M Sell
46,098
-5,295
-10% -$858K 0.19% 71
2021
Q4
$6.96M Buy
51,393
+7,113
+16% +$963K 0.21% 59
2021
Q3
$4.78M Buy
44,280
+8,773
+25% +$946K 0.12% 69
2021
Q2
$4M Buy
35,507
+4,494
+14% +$506K 0.12% 74
2021
Q1
$3.36M Buy
31,013
+814
+3% +$88.1K 0.12% 74
2020
Q4
$3.24M Sell
30,199
-263
-0.9% -$28.2K 0.15% 73
2020
Q3
$2.67M Buy
30,462
+1,165
+4% +$102K 0.14% 70
2020
Q2
$2.88M Buy
29,297
+1,608
+6% +$158K 0.18% 62
2020
Q1
$2.11M Sell
27,689
-28,602
-51% -$2.18M 0.18% 79
2019
Q4
$4.98M Buy
56,291
+8,022
+17% +$710K 0.35% 31
2019
Q3
$3.66M Buy
48,269
+28,501
+144% +$2.16M 0.2% 35
2019
Q2
$1.44M Buy
19,768
+306
+2% +$22.2K 0.2% 94
2019
Q1
$1.57M Buy
19,462
+1,250
+7% +$101K 0.27% 92
2018
Q4
$1.68M Buy
+18,212
New +$1.68M 0.44% 20